NCT00471432View on ClinicalTrials.gov

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 4, 2003

Primary Completion Date

March 9, 2006

Study Completion Date

December 21, 2009

Conditions
Bladder CancerBreast CancerKidney CancerLung CancerOvarian CancerProstate CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

custirsen sodium

DRUG

docetaxel

OTHER

pharmacological study

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK